Access to Migraine Treatment

The MP highlighted the challenges faced by chronic migraine sufferers, who are triggered endlessly by light and noise. She emphasized the need to consider migraine as a disability due to its debilitating impact on employment. The MP also discussed the stigma surrounding migraines, mentioning her personal experience with beta blockers and Botox treatments.

The hon. Member shared his personal experience of living with migraines since adolescence and managing symptoms through stress reduction methods.

He highlighted the impact of migraines on individuals and families, noting that one in seven people suffer from migraine with over 1 million experiencing chronic migraine. He shared personal experience of living with someone who suffers from chronic migraine and stressed the debilitating nature of the condition which can severely disrupt daily activities. Williamson cited statistics showing 29% of sufferers had to reduce their working hours due to migraines, while 43% felt they were not believed by their employers when reporting a migraine episode. He called for better understanding in workplaces to support those suffering from migraines and advocated for more investment in treatment and research. Mr Williamson intervened to ask the Minister to consider CGRP blockers further, indicating a potential interest in an announcement about them. He sought reassurance that these treatments would be looked into more closely.

Congratulated the hon. Member on securing the debate and suggested there should be discussion with devolved institutions to ensure blockers are more widely available across the UK.

Ms Smyth highlighted that one in seven people in the UK live with migraine, disproportionately affecting women. She noted the debilitating nature of migraines and their impact on employment, noting that 29% of sufferers have moved from full-time to part-time work or left jobs altogether due to the condition. Ms Smyth also expressed concern about long waiting lists for specialist treatment and called for more ambitious measures to tackle economic inactivity caused by migraine.

A constituent reported frustration due to a lack of awareness among medical professionals about specific treatments for hormonal migraines, suggesting that greater knowledge among GPs is essential.

Commends the hon. Member for Bishop Auckland on raising awareness of migraine and highlights personal experience. Emphasizes the need for better understanding and access to treatment, mentioning long waiting times in Scotland, England, and Wales. Discusses potential alternatives like psilocybin and calls for more research despite challenges due to drug classification. Acknowledges progress but stresses that more needs to be done regarding flexible working rights and GP specialisation.

Noted that many migraine sufferers face difficulties in accessing benefits like personal independence payment due to the unpredictable nature of their condition, impacting their ability to work and live a normal life. Called for more support from the Department of Work and Pensions to help people with chronic migraine access disability benefits.

A constituent, Lisa, has written to express her struggles with migraines that leave her exhausted and suffering from facial paralysis and other symptoms. She is glad the debate is taking place.

Although not present, the hon. Member sent a testimonial highlighting his ability to minimise migraine severity and frequency over time by managing stress.